Dr. Mina S. Ally, MD

Dr. Ally practices at Palo Alto Medial Foundation in San Jose, California.

Dr. Ally's NPI, 1528467099, was assigned on August 20, 2014. Dr. Ally graduated from (King's College London - School of Medicine) in 2009. Dr. Ally holds California license 144146.

Dr. Ally's primary practice is Palo Alto Medial Foundation, at 1071 Blossom Hill Rd, San Jose, CA 95123-1105. The practice phone is (408) 445-4010.

Dr. Ally's primary practice is Palo Alto Medial Foundation in San Jose, California. The medical group on file is The Permanente Medical Group, Inc. Dmand AI also links Dr. Ally to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ally practices. Vendor and product names are available with a free account.

Dermatology is Dr. Ally's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Ally is board certified in dermatology by the American Board of Dermatology. Dr. Ally is licensed in California.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, contact dermatitis, corns and calluses, itchy rashes, psoriasis and rash among the conditions Dr. Ally treats.

CMS data shows 1,017 Medicare services from Dr. Ally across 9 procedure codes in 2024, for 244 Medicare patients. Medicare paid $63,597 for them. Every service was in an office.

CMS counts 244 Medicare patients who saw Dr. Ally in 2024. The largest group is 65 to 74, with 129 patients. 70% of them have high cholesterol, and 55% have high blood pressure. 11% are also on Medicaid. Their average risk score is 0.88, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ally's median patient age at 49, with 60% women.

In 2024, Dr. Ally wrote 531 Medicare Part D claims for 220 patients. 86% of them were for generic drugs. CMS names the drug for 403 of them, across 12 drugs with 11 or more claims each, at $185,617 in total drug cost. In 2023, CMS named 1,510 claims across 29 drugs.

Dr. Ally accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ally as offering telehealth. CMS counts 544 procedures of removal of skin lesions by Dr. Ally, more than 87% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 25 papers to Dr. Ally, published from 2012 to 2021. 2013 was the busiest year, with 5. The most frequent topics are Skin Neoplasms, Carcinoma, Basal Cell and Anilides. Dr. Ally has published most often in JAMA Dermatol. Dr. Ally's most frequent co-authors are Ervin Epstein, MD, Anthony Eugene Oro, MD and Anne Lynn Su Chang, MD.

CMS Open Payments shows 227 general payments to Dr. Ally from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Janssen Pharmaceuticals, Inc paid the most, $891.

Dr. Ally graduated from (King's College London - School of Medicine) in 2009.

Dr. Ally is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.